Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Exenatide

DRUG

Biphasic insulin Aspart 30

Trial Locations (1)

710032

Xijing Hospital, Fourth Military Medical university, Xi'an

All Listed Sponsors
collaborator

Air Force Military Medical University, China

OTHER

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER

collaborator

Shaanxi Provincial People's Hospital

OTHER

collaborator

Chang'An Hospital

OTHER

collaborator

Xi'an Gaoxin Hospital

OTHER

collaborator

Xi'an Central Hospital

OTHER

collaborator

Shaanxi Aerospace Hospital

UNKNOWN

lead

Xijing Hospital

OTHER

NCT02449603 - Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes | Biotech Hunter | Biotech Hunter